USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market
Growing Prominence of Single Use Technologies and Biologics Market Driving Growth
14-Feb-2017
North America
Market Research
9AB9-00-6A-00-00
HC02722-NA-MR_19397
$1,500.00
Special Price $1,125.00 save 25 %
This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020.
The pharma E&L testing market is expected to expand at a compound annual growth rate of 12.1% from 2015 to 2020, driven by the increasing adoption of single use technologies, increased demand due to stringent regulatory scrutiny, CROs evolving as development partners and increasing prominence of biologics leading to need for comprehensive E&L testing programs. With the increasing prominence of single use systems (SUS), the global E&L testing market is expected to experience a robust growth. Emerging markets such as India and China are becoming hubs for contract manufacturing for such services, as these countries are building strong local expertise in analytical laboratory testing.
The pharma industry is becoming more aware of the impact of E&L for protection of patients, leading to increased and stringent scrutiny by regulatory agencies. Bio/Pharma companies are increasingly outsourcing these services to reduce the burden on internal staff and also expedite the time to market for drugs.
Key Findings
Scope and Segmentation
Overview—Pharma Extractables and Leachables
Packaging Concerns in Drug Products
Designing Extractables and Leachables Tests
Revenue Forecast
Revenue Forecast Discussion
Overall Trends in Pharma Extractables and Leachables
Trends in Pharma Extractables and Leachables—E&L Testing for SUS
Trends in Pharma Extractables and Leachables—E&L Testing for SUS (continued)
Regulatory Scenario in Pharma Extractables and Leachables Testing Market
Overview of Pharma Extractables and Leachables Outsourcing
Special Considerations Required for Large Molecules in Pharma E&L Testing
Regional Trends in Pharma Extractables and Leachables
Advances in Extractables and Leachables Technology
Customer Analysis
Growth Opportunities for Extractables and Leachables Market
Competitive Analysis—Selected Key Market Participants Intertek
Competitive Analysis—Selected Key Market Participants Smithers Rapra
Competitive Analysis—Selected Key Market Participants Toxikon
Pharma Extractables and Leachables—Indian Market Scenario
Indian Competitors in the Pharma Extractables and Leachables Market
Indian Competitors in the Pharma Extractables and Leachables Market (continued)
The Last Word
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Shweta Pankaj |
| Industries | Healthcare |
| WIP Number | 9AB9-00-6A-00-00 |
| Is Prebook | No |